Accrual and retention of diverse patients in psychosocial cancer clinical trials

被引:5
|
作者
Hanvey, Grace Ann [1 ]
Padron, Adaixa [1 ]
Kacel, Elizabeth L. [1 ]
Cartagena, Gabriel [1 ]
Bacharz, Kelsey C. [1 ]
McCrae, Christina S. [1 ]
Robinson, Michael E. [1 ]
Waxenberg, Lori B. [1 ]
Antoni, Michael H. [2 ]
Berry, Richard B. [3 ]
Schultz, Gregory S. [4 ]
Castagno, Jacqueline [4 ]
Pereira, Deidre B. [1 ]
机构
[1] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA
[2] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA
[3] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA
[4] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
Cancer; clinical trials; recruitment; retention; health disparities; SLEEP QUALITY INDEX; PSYCHOMETRIC PROPERTIES; PARTICIPATION; POPULATIONS; MINORITIES; INVENTORY; BARRIERS; HEALTH; PAIN;
D O I
10.1017/cts.2022.380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to examine sociodemographic inequities in CCT interest, eligibility, enrollment, decline motivation, and attrition across two psychosocial CCTs for gynecologic, gastrointestinal, and thoracic cancers. Methods: Patients were approached for recruitment to one of two interventions: (1) a randomized control trial (RCT) examining effects of a cognitive-behavioral intervention targeting sleep, pain, mood, cytokines, and cortisol following surgery, or (2) a yoga intervention to determine its feasibility, acceptability, and effects on mitigating distress. Prospective RCT participants were queried about interest and screened for eligibility. All eligible patients across trials were offered enrollment. Patients who declined yoga intervention enrollment provided reasons for decline. Sociodemographic predictors of enrollment decisions and attrition were explored. Results: No sociodemographic differences in RCT interest were observed, and older patients were more likely to be ineligible. Eligible Hispanic patients across trials were significantly more likely to enroll than non-Hispanic patients. Sociodemographic factors predicted differences in decline motivation. In one trial, individuals originating from more urban areas were more likely to prematurely discontinue participation. Discussion: These results corroborate evidence of no significant differences in CCT interest across minority groups, with older adults less likely to fulfill eligibility criteria. While absolute Hispanic enrollment was modest, Hispanic patients were more likely to enroll relative to non-Hispanic patients. Additional sociodemographic trends were noted in decline motivation and geographical prediction of attrition. Further investigation is necessary to better understand inequities, barriers, and best recruitment practices for representative CCTs.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Negative results in cancer clinical trials - equivalence or poor accrual?
    Costa, LJM
    Xavier, ACG
    del Giglio, A
    CONTROLLED CLINICAL TRIALS, 2004, 25 (05): : 525 - 533
  • [22] Hispanic Accrual on Randomized Cancer Clinical Trials: A Call to Arms
    Parra, Alberto
    Karnad, Anand B.
    Thompson, Ian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1871 - +
  • [23] Accrual to lung cancer clinical trials - a single centre experience
    Plant, R.
    Walter, H.
    Samuel, D.
    Fennell, D. A.
    Ahmed, S. I.
    LUNG CANCER, 2014, 83 : S15 - S16
  • [24] Enhancing accrual to clinical trials of adolescents and young adults with cancer
    Fern, Lorna A.
    Taylor, Rachel M.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (09)
  • [25] Strategies for increasing accrual in cancer clinical trials: What is the evidence?
    Michaels, Margo
    Weiss, Elisa S.
    Sae-Hau, Maria
    Illei, Dora
    Lilly, Bethany
    Szumita, Leah
    Connell, Brian
    Lee, Marialanna
    Cooks, Eric
    McPheeters, Melissa
    CANCER MEDICINE, 2024, 13 (10):
  • [26] Accrual Of Patients With Relapsed and Refractory DLBCL Onto Clinical Trials
    Marton, Ashley
    Kezouh, Abbas
    Assouline, Sarit
    BLOOD, 2013, 122 (21)
  • [28] Association between state Medicaid policies and accrual of Black and Hispanic patients to cancer clinical trials
    Takvorian, Samuel U.
    Schpero, William L.
    Blickstein, Daniel
    Shafquat, Afrah
    Liu, Jingshu
    Chatterjee, Arnaub
    Lamont, Elizabeth B.
    Chatterjee, Paula
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Association Between State Medicaid Policies and Accrual of Black or Hispanic Patients to Cancer Clinical Trials
    Schpero, William L.
    Takvorian, Samuel U.
    Blickstein, Daniel
    Shafquat, Afrah
    Liu, Jingshu
    Chatterjee, Arnaub K.
    Lamont, Elizabeth B.
    Chatterjee, Paula
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (27)
  • [30] Patients' retention strategies in clinical trials
    Mezquita Raya, Pedro
    Reyes Garcia, Rebeca
    de Torres Sanchez, Alejandra
    ENDOCRINOLOGIA Y NUTRICION, 2015, 62 (10): : 475 - 477